key: cord-0792263-jbxb2sp5 authors: Nagler, Adi; Kalaora, Shelly; Barbolin, Chaya; Gangaev, Anastasia; Ketelaars, Steven L.C.; Alon, Michal; Pai, Joy; Benedek, Gil; Yahalom-Ronen, Yfat; Erez, Noam; Greenberg, Polina; Yagel, Gal; Peri, Aviyah; Levin, Yishai; Satpathy, Ansuman T.; Bar-Haim, Erez; Paran, Nir; Kvistborg, Pia; Samuels, Yardena title: Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics date: 2021-06-08 journal: Cell Rep DOI: 10.1016/j.celrep.2021.109305 sha: cc09f347cb6be6eb84e8711474ef819f53a04a08 doc_id: 792263 cord_uid: jbxb2sp5 The human leukocyte antigen (HLA)-bound-viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of viral presented antigens. Utilizing HLA-peptidomics we were able to identify SARS-CoV-2-derived peptides presented by highly prevalent HLA Class-I (HLA-I) molecules using infected cells as well as overexpression of SARS-CoV-2 genes. We found 26 HLA-I peptides and 36 HLA class-II (HLA-II) peptides. Among the identified peptides some were shared between different cells and some were derived from out-of-frame-ORFs. Seven of these peptides were previously shown to be immunogenic, and we identify two additional immuno-reactive peptides using HLA-multimer staining. These results may aid the development of the next generation of SARS-CoV-2 vaccines based on viral-specific-presented antigens that span several of the viral genes. CoV-2 genes 104 To assess the presentation of viral peptides both by endogenous and We overexpressed the SARS-CoV-2 envelope, membrane, nuclocapsid and 123 nonstructural protein 6 (nsp6) genes in the B cells outlined above. We specifically 124 focused on these four genes as previous studies, using pools of predicted 125 peptides derived from these four SARS-CoV-2 genes, showed a high frequency 126 of reactive T cells from exposed and unexposed individuals (Grifoni et 154 To complement our overexpression system, we infected the IHW01070, 155 HEK293T stably expressing ACE2 and Calu-3 cell lines with SARS-CoV-2. First, 156 we confirmed these cells express the angiotensin-converting enzyme 2 (ACE2) 157 receptor and transmembrane protease serine 2 (TMPRSS), known to be required We assessed whether any SARS-CoV-2 peptides in the infected cells may be 164 derived from non-canonical ORFs, using a recently published novel ORFs (Finkel 165 et al., 2020a). Indeed, we were able to identify 2 HLA-I peptides derived from 166 internal out-of-frame ORFs present in the coding region of spike and 167 nucleocapsid in HEK239T cells. GPMVLRGLIT was identified from S.iORF1/2, 168 and was predicted to bind the B*07:02 allele, and SLEDKAFQL from ORF9b (an 169 internal out-of-frame ORF in the coding region of nucleocapsid), and was 170 predicted to bind the A*02:01 and C*07:02 alleles. (Table S1) . Table S1 ). Peptide similarity to other corona viruses and to the human proteome 252 We assessed the similarity of identified SARS-CoV-2 peptides to the proteome of 253 other coronavirus family members to which one might have prior immunity. In addition, none of our identified peptides were found among the different strains 266 of the SARS-CoV-2 SNPs, suggesting that these peptides could be used for 267 patients infected with different SARS-CoV-2 strains. We compared the amino acid sequence of the SARS-CoV-2 peptides that were 270 predicted to bind the most frequent alleles to the human genome. We found 2 271 different peptides that had the exact same sequence and that 281/9836 unique We selected to test for CD8+ T cell recognition two SARS-CoV-2 HLA-I peptides 316 identified in this study that were not previously tested for reactivity and were Figure S1 ). (This experiment is related to Figures 3-4 , S1). diameter, 250 mm length, 1.8 µm particle size; Waters) at 0.35 µL/minute. Peptides were eluted from the column into the mass spectrometer using the 620 following gradient: 5% to 28%B in 120 minutes, 28% to 35%B in 15 minutes, 621 35% to 95% in 15 minutes, maintained at 95% for 10 minutes and then back to 622 initial conditions. The nanoUPLC was coupled online through a nanoESI emitter (10 µm tip; New We validated the identification of randomly selected peptides by comparing their 671 MS/MS spectra fragmentation to that of synthetic peptides (see methods: 672 "Validation using synthetic peptides"). We also clustered human and SARS-CoV-673 2 derived peptides using Gibbs clustering, to see if they clustered according to 674 the expected HLA binding motifs of the patient (see methods: "Gibbs clustering"). (This experiment is related to Figures 2-4 , S1-S2). and a maximum of two miscleavages was allowed. Peptide-and protein-level 797 false discovery rates (FDRs) were filtered to 1% using the target-decoy strategy. (This experiment is related to Figure 2 ). Defining HLA-II Ligand Processing and Binding Rules 929 with Mass Spectrometry Enhances Cancer Epitope Prediction Mass Spectrometry Profiling of HLA-Associated 932 Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction GibbsCluster: unsupervised clustering and 935 alignment of peptide sequences Simultaneous alignment and clustering of 937 peptide data using a Gibbs sampling approach Direct identification of clinically relevant 940 neoepitopes presented on native human melanoma tissue by mass spectrometry Deciphering HLA-I motifs across HLA peptidomes 944 improves neo-antigen predictions and identifies allostery regulating HLA specificity T cell and antibody kinetics delineate SARS-CoV-2 948 peptides mediating long-term immune responses in COVID-19 convalescent individuals Host-Viral Infection Maps Reveal Signatures of Severe COVID-952 19 Patients Prediction of SARS-CoV-954 2 epitopes across 9360 HLA class I alleles. bioRxiv Pervasive functional translation of noncanonical human 957 open reading frames MHC class II antigen processing 959 in B cells: accelerated intracellular targeting of antigens Induction of T-cell response by 961 a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus 962 epitope Integrated proteogenomic deep sequencing and analytics 965 accurately identify non-canonical peptides in tumor immunopeptidomes MaxQuant enables high peptide identification rates, individualized 968 p.p.b.-range mass accuracies and proteome-wide protein quantification Most viral peptides displayed by class I MHC on 972 infected cells are immunogenic Immunological memory to SARS-CoV-2 assessed for up to 8 months 975 after infection Novel human coronavirus (SARS-CoV-2): A lesson from 977 animal coronaviruses The coding capacity of SARS-CoV-2. 980 Nature Comprehensive annotations of human 983 herpesvirus 6A and 6B genomes reveal novel and conserved genomic features MSnbase-an R/Bioconductor package for isobaric tagged mass 985 spectrometry data visualization, processing and quantitation The Length Distribution and Multiple Specificity of Naturally Presented 988 HLA-I Ligands A SARS-CoV-2-Human Protein-Protein 991 Interaction Map Reveals Drug Targets and Potential Drug-Repurposing Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals Multiple organ infection and the pathogenesis of SARS Parallel detection of antigen-specific T-cell 1000 responses by multidimensional encoding of MHC multimers SARS-CoV-2 Cell Entry Depends on ACE2 and 1003 TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4(+) T Cells 1006 upon Immunization with a Virus-Derived Nanoparticle Antigen NetMHCpan, a method for MHC class I binding prediction beyond humans Ribosome profiling reveals pervasive translation outside of 1012 annotated protein-coding genes Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling Ribosome Profiling of Mouse Embryonic 1017 Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes An mRNA Vaccine 1020 against SARS-CoV-2 -Preliminary Report Improved methods for predicting peptide binding affinity to MHC class II 1023 molecules Immunological considerations for COVID-19 vaccine strategies Epitope based vaccine prediction for 1027 SARS-COV-2 by deploying immuno-informatics approach NetMHCpan-1029 4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide 1030 Binding Affinity Data Use of HLA peptidomics and whole 1033 exome sequencing to identify human immunogenic neo-antigens Identification of bacteria-derived HLA-bound peptides in 1036 melanoma Combined Analysis of Antigen Presentation and Recognition Reveals Restricted Immune Responses in Melanoma Bioinformatic prediction of 1041 potential T cell epitopes for SARS-Cov-2 Antigen processing by the proteasome An improved model for prediction of retention times of tryptic peptides in ion pair reversed-1045 phase HPLC: its application to protein peptide mapping by off-line HPLC-MALDI MS SARS-CoV-2-specific T cell immunity in cases of COVID-19 and 1049 SARS, and uninfected controls Epitope-based peptide 1051 vaccines predicted against novel coronavirus disease caused by SARS-CoV-2 The antigenic identity of peptide-MHC 1054 complexes: a comparison of the conformations of five viral peptides presented by HLA-A2 Selective and cross-reactive SARS-CoV-2 T cell epitopes in 1058 unexposed humans Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells Protocol Update for large-scale genome and gene function analysis with the PANTHER 1064 classification system (v.14.0) Longitudinal high-throughput TCR 1067 repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 1068 infection. bioRxiv Publisher Correction: Phase I/II study of COVID-19 RNA 1071 vaccine BNT162b1 in adults SARS-CoV-2-derived peptides define heterologous and 1074 COVID-19-induced T cell recognition Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome 1077 Coronavirus 2 NetMHCpan-3.0; improved prediction of binding to MHC 1079 class I molecules integrating information from multiple receptor and peptide length datasets Pervasive generation of non-canonical 1082 subgenomic RNAs by SARS-CoV-2 Synthetic peptides coupled to the surface of liposomes 1085 effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-1086 A*0201 transgenic mice Thousands of novel unannotated proteins expand the 1089 MHC I immunopeptidome in cancer. bioRxiv Infection of human lymphomononuclear 1092 cells by SARS-CoV-2. bioRxiv Sequence-based prediction of 1095 SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies 1096 immunogenic T cell epitopes Non-canonical open reading frames encode 1099 functional proteins essential for cancer cell survival. bioRxiv Functional SARS-CoV-2-1102 Specific Immune Memory Persists after Mild COVID-19 Generation of peptide-MHC class I complexes through UV-mediated ligand 1105 exchange A large peptidome dataset improves HLA class I epitope 1108 prediction across most of the human population Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: 1111 rapid induction, prolonged contraction, and formation of functional memory. bioRxiv Robust T Cell Immunity in 1115 Convalescent Individuals with Asymptomatic or Mild COVID-19 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors Magnitude and Dynamics of the T-Cell 1122 Response to SARS-CoV-2 Infection at Both Individual and Population Levels Cleavage and secretion of Epstein-Barr 1124 virus glycoprotein 42 promote membrane fusion with B lymphocytes Herpesvirus entry: an update Nowhere to hide: unconventional translation yields cryptic 1127 peptides for immune surveillance Decoding Human Cytomegalovirus SARS CTL vaccine candidates; HLA supertype-, 1133 genome-wide scanning and biochemical validation Comprehensive analysis of T cell immunodominance and 1136 immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases Seq2Logo: a method for construction and visualization 1138 of amino acid binding motifs and sequence profiles including sequence weighting, pseudo 1139 counts and two-sided representation of amino acid enrichment and depletion T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike 1143 proteins The Perseus computational platform for comprehensive analysis of (prote)omics data The Immune Epitope Database (IEDB): 2018 update Receptor Recognition by the Novel 1151 Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS 1152 Coronavirus Frequent display of 1155 human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as 1156 witness of previous viral encounter Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2 Affinity-Restricted Memory B Cells Dominate 1162 Recall Responses to Heterologous Flaviviruses A single dose of recombinant VSV-ΔG-spike vaccine 1165 provides protection against SARS-CoV-2 challenge. bioRxiv Increased cytotoxic T-lymphocyte epitope variant 1168 cross-recognition and functional avidity are associated with hepatitis C virus clearance Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and 1175 CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells A pneumonia outbreak associated with a new coronavirus of probable bat origin A Novel Coronavirus from Patients with Pneumonia in China SARS-CoV-2-derived peptides presented by highly prevalent HLA-I and HLA-II. Identified peptides are derived from various canonical and non-canonical viral ORFs, are shared between different cells and are immunogenic. As the identified peptides are unique to SARS-CoV-2 Highlights • HLA peptidomics enable the identification of SARS-CoV-2 derived HLA peptides • SARS-CoV-2 peptides can be derived from canonical and non-canonical ORFs • Shared SARS-CoV-2 peptides are identified in different cell types • Several SARS-CoV-2 peptides are immunogenic